GlaxoSmithKline Pharmaceuticals informs board meeting

03 May 2021 Evaluate

Pursuant to clause 33 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 18th May 2021, to consider amongst other things, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended 31st March 2021 and to recommend dividend, if any, on the equity shares of the Company.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2394.00 4.65 (0.19%)
31-Dec-2025 12:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1266.65
Cipla 1503.00
Zydus Lifesciences 913.65
Lupin 2105.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×